Koen Jolling

Koen joined qPharmetra in July 2018. He obtained a M.Sc. in Biology from the Catholic University of Leuven (Belgium) in 2001 and his PhD, entitled “Chronic exposure of mice to cadmium: toxic effects on the renal proximal tubule”, from Hasselt University in 2008. In between his studies, Koen worked for approximately 2 years as a data analyst in the department of Global Clinical Pharmacokinetics and Clinical Pharmacodynamics of Johnson & Johnson Pharmaceutical Reasearch and Develoment, Beerse, Belgium. In this role he contributed to Phase I through III development programs for PK and PK/PD work in various therapeutic areas. After his PhD Koen assumed several roles where he was responsible for PK and PK/PD related work of in vitro, ADME and toxicokinetic studies, co-responsible for strategic planning of in vitro and (pre)clinical in vivo research including design/optimization of target product profiles and decision trees, mapping out of (pre)clinical drug development programs (infectious disease, gastro intestinal tract and virology), CRO selection and writing grant applications. Furthermore, Koen headed the pharmacokinetic and toxicokinetic department and later on as a consultant he was involved in executing modeling and simulation activities to support the implementation of the clinical pharmacology strategy.